Key abstracts being presented at ASH 2017
Precision medicine for MDS, what drugs for which patients?
Finding novel treatment options for relapsed/progressing AML
Advantages of chemotherapy and hypomethylating agents in myelodysplastic syndrome
Maria Teresa Voso
Current and future advancements in the treatment of CLL